Scinai Immunotherapeutics Ltd. (SCNI) stock
SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.75−0.00 (-0.32%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Scinai Immunotherapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Scinai Immunotherapeutics's pe ratio was 6.4× on Feb 27, 2026, against 2.2× a year earlier. Over the last 3 years it ranged from 1.2× to 6.4×, with a median of 2.9×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Feb 27, 2026 | 6.4× | +4.2 |
| 2025 | Dec 31, 2025 | 2.2× | +0.2 |
| 2024 | Dec 31, 2024 | 2.1× | +0.6 |
| 2023 | Dec 29, 2023 | 1.5× | – |
See a number that looks wrong?